​

Evommune Ownership | Who Owns Evommune?

OverviewRevenueFinancialsChart

Evommune Ownership Summary

Evommune is owned by 109.00% institutional investors, 7.98% insiders. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 15.64% of EVMN shares.

EVMN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEvommune109.00%7.98%-16.98%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustryBiotech Stocks 35.37%11.83%52.80%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eqt fund management s.a r.l.4.93M15.64%$113.33M
Ra capital management3.49M11.09%$80.34M
Pivotal bioventure partners investment advisor1.93M6.11%$44.30M
Andera partners1.90M6.02%$43.62M
Rtw investments, lp1.50M4.77%$34.54M
Jpmorgan chase1.46M4.63%$32.11M
Bioimpact capital1.46M4.62%$33.47M
Nan fung group1.44M4.57%$33.13M
Eventide asset management1.21M3.84%$27.80M
Price t rowe associates inc /md/1.12M3.55%$25.73M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group1.44M27.32%$33.13M
Andera partners1.90M24.66%$43.62M
Pivotal bioventure partners investment advisor1.93M15.83%$44.30M
Sectoral asset management589.00K11.22%$13.54M
Eqt fund management s.a r.l.4.93M11.10%$113.33M
Velan capital investment management lp446.25K6.43%$10.26M
Bioimpact capital1.46M2.58%$33.47M
Monashee investment management179.34K2.24%$4.12M
Great point partners325.00K1.72%$7.47M
Kynam capital management, lp625.50K0.89%$14.38M

Top Buyers

HolderShares% AssetsChange
Bioimpact capital1.46M2.58%1.34M
Janus henderson group896.70K0.01%896.70K
Baker bros. advisors lp847.39K0.11%847.39K
Alyeska investment group726.36K0.05%726.36K
Blackrock funding, inc. /de673.57K0.00%531.13K

Top Sellers

HolderShares% AssetsChange
Abrdn---525.38K
Octagon capital advisors lp143.47K0.36%-356.53K
Sofinnova investments---153.32K
Marshall wace, llp879.73K0.02%-108.47K
Sphera funds management78.23K0.29%-87.91K

New Positions

HolderShares% AssetsChangeValue
Janus henderson group896.70K0.01%896.70K$20.62M
Baker bros. advisors lp847.39K0.11%847.39K$19.48M
Alyeska investment group726.36K0.05%726.36K$16.70M
Perceptive advisors448.35K0.20%448.35K$10.31M
Freestone grove partners lp337.29K0.05%337.29K$7.75M

Sold Out

HolderChange
Royal bank of canada-585.00
Oxford asset management llp-19.57K
Two sigma investments, lp-21.32K
Qube research-24.06K
Tudor investment corp et al-31.95K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20268137.29%34,361,90526.33%1091.46%613.39%11-
Dec 31, 202559-27,200,904-86-59---

EVMN Ownership FAQ

Who Owns Evommune?

Evommune shareholders are primarily institutional investors at 109.00%, followed by 7.98% insiders and -16.98% retail investors. The average institutional ownership in Evommune's industry, Biotech Stocks , is 35.37%, which Evommune exceeds.

Who owns the most shares of Evommune?

Evommune’s largest shareholders are Eqt fund management s.a r.l. (4.93M shares, 15.64%), Ra capital management (3.49M shares, 11.09%), and Pivotal bioventure partners investment advisor (1.93M shares, 6.11%). Together, they hold 32.84% of Evommune’s total shares outstanding.

Does Blackrock own Evommune?

BlackRock is not among the top 10 institutional shareholders of Evommune.

Who is Evommune’s biggest shareholder by percentage of total assets invested?

Nan fung group is Evommune’s biggest shareholder by percentage of total assets invested, with 27.32% of its assets in 1.44M Evommune shares, valued at 33.13M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools